These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 33259133)
1. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer. Jiang W; Zhu D; Wang C; Zhu Y Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133 [TBL] [Abstract][Full Text] [Related]
2. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1. Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/β-catenin signalling pathway. Yuan H; Yu S; Cui Y; Men C; Yang D; Gao Z; Zhu Z; Wu J J Cell Mol Med; 2017 Dec; 21(12):3254-3263. PubMed ID: 28631286 [TBL] [Abstract][Full Text] [Related]
4. Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function. Berglund AE; Scott KE; Li W; Yang C; Fernandez MR; Schaub FX; Cleveland JL; Rounbehler RJ Oncotarget; 2016 Dec; 7(50):83462-83475. PubMed ID: 27825143 [TBL] [Abstract][Full Text] [Related]
5. circST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis. Tan S; Kang Y; Li H; He HQ; Zheng L; Wu SQ; Ai K; Zhang L; Xu R; Zhang XZ; Zhao XK; Zhu X Cell Death Dis; 2021 Feb; 12(2):168. PubMed ID: 33568625 [TBL] [Abstract][Full Text] [Related]
6. Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 (CIP1/WAF1) expression. Wang C; Ge Q; Chen Z; Hu J; Li F; Ye Z Tumour Biol; 2016 May; 37(5):6589-98. PubMed ID: 26643891 [TBL] [Abstract][Full Text] [Related]
7. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621 [TBL] [Abstract][Full Text] [Related]
8. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1. Tian Z; Cao S; Li C; Xu M; Wei H; Yang H; Sun Q; Ren Q; Zhang L J Cell Physiol; 2019 Apr; 234(4):4799-4811. PubMed ID: 30317572 [TBL] [Abstract][Full Text] [Related]
9. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis. Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578 [TBL] [Abstract][Full Text] [Related]
11. Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis. Fan L; Yang J; Shen C; Wu Z; Hu H Acta Histochem; 2021 Jul; 123(5):151745. PubMed ID: 34175686 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑154 functions as a tumor suppressor in bladder cancer by directly targeting ATG7. Zhang J; Mao S; Wang L; Zhang W; Zhang Z; Guo Y; Wu Y; Yi F; Yao X Oncol Rep; 2019 Feb; 41(2):819-828. PubMed ID: 30483807 [TBL] [Abstract][Full Text] [Related]
13. Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis. Wang C; Ge Q; Zhang Q; Chen Z; Hu J; Li F; Ye Z J Exp Clin Cancer Res; 2016 Mar; 35():53. PubMed ID: 27012825 [TBL] [Abstract][Full Text] [Related]
14. Aberrant FBXW7-mediated ubiquitination and degradation of ZMYND8 enhances tumor progression and stemness in bladder cancer. Qiu F; Jin Y; Pu J; Huang Y; Hou J; Zhao X; Lu Y Exp Cell Res; 2021 Oct; 407(2):112807. PubMed ID: 34487730 [TBL] [Abstract][Full Text] [Related]
15. METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS. Chen JX; Chen DM; Wang D; Xiao Y; Zhu S; Xu XL Oncol Rep; 2023 May; 49(5):. PubMed ID: 36960869 [TBL] [Abstract][Full Text] [Related]
16. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression. Meng L; Xing Z; Guo Z; Liu Z Cell Death Dis; 2020 Dec; 11(12):1063. PubMed ID: 33311496 [TBL] [Abstract][Full Text] [Related]
17. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages. Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166 [TBL] [Abstract][Full Text] [Related]
18. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA. Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158 [TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling. Huang SY; Chang SF; Liao KF; Chiu SC Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590 [TBL] [Abstract][Full Text] [Related]
20. Stability of the LATS2 tumor suppressor gene is regulated by tristetraprolin. Lee HH; Vo MT; Kim HJ; Lee UH; Kim CW; Kim HK; Ko MS; Lee WH; Cha SJ; Min YJ; Choi DH; Suh HS; Lee BJ; Park JW; Cho WJ J Biol Chem; 2010 Jun; 285(23):17329-37. PubMed ID: 20335167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]